Drugs / SCL-3010
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07269158 Comparator | Dec 2025 → Sep 2029 expected | biliary tract neoplasm | Yonsei University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCL-3010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07269158 ↗ |